Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France.

Engages in priniting activities

Part of Kitasato University, The Kitasato Institute is a company headquartered in Tokyo, Japan, that operates a research institution.

Gagawu (Zhuhai) Biotechnology Co., Ltd., established on 2018-03-13, Business scope includes general items:Natural science research and experimental development;Medical Research and Experimental Development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);Socioeconomic Advisory Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;production of agricultural products,Sales,processing,transportation,Storage and other related services;internet sales(Except for products that require a license for sale);Domestic trade agent;food sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Professional cleaning,to clean,Disinfection service;building cleaning service.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Part of Zoetis, Inc., Rhone Merieux is a company headquartered in France that manufactures pharmaceuticals, speciality and agricultural chemicals.

Operates as a clinical stage biopharmaceutical company

Zhuhai Yufan Biotechnology Co., Ltd., established on 2017-03-27, Business scope includes medical research and experimental development(remove human stem cells,Development and application of genetic diagnosis and treatment technology);Data processing and storage support services;Information Technology Consulting Services;Socioeconomic Advisory Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;Software outsourcing service;software development;Engage in investment activities with own funds;Import and export;Natural science research and experimental development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Founded in 1968 in Carros close to Nice by Pierre-Richard Dick (DVM), Virbac is dedicated exclusively to animal health. With a turnover of €736 million in 2013, the company ranks today as the 8th largest animal health company worldwide. Its wide range of vaccines and medicines are used in the prevention and treatment of the main pathologies for both companion and food-producing animals. Over the last forty years Virbac has become a recognised expert in the sector, offering products and services that combine quality, effectiveness and convenience for veterinarians, farmers and animal owners. Present in more than 100 countries the company has more than 4,350 employees. Quoted on the Paris Stock Exchange since 1985 Virbac has remained a family company, not only as regards its shareholding but also through its management principles, its culture and its company values. International presence has been an integral part of Virbac's strategy since the very beginning. Starting in 1978, Virbac expansion abroad speeded up progressively in the 1980s and then in the 1990s. Today Virbac is present in all 5 continents, with around 85% of its sales made outside of France.

The Institut national de la recherche agronomique (INRA, pronounced [inʁa]; English: National Institute of Agricultural Research) is a French public research institute dedicated to agricultural science. It was founded in 1946 and is a Public Scientific and Technical Research Establishment under the joint authority of the Ministries of Research and Agriculture.

Markets and distributes specialty, artisanal and farmstead cheese products

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Suzhou Wangshan Wangshui Bio-Pharmaceutical Co., Ltd., established on 2013-01-21, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Health food production;Health food sales;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development;R&D and application of cell technology;Biochemical product technology research and development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

ID-Lelystad Instituut Voor Dierhouderij En Diergezondheid BV is a private company headquartered in Lelystad, the Netherlands. The firm engages in research and development on livestock.

Virbac Corp. used to provide dermatological and oral hygiene products for pets and companion animals. The company brands included C.E.T. Home Dental Care, Allerderm, Preventic Tick Collars and Per-Tabs. Virbac was formed on March 5, 1999 and it was headquartered in Fort Worth, TX.

Jiaxing Jinpaite Biotechnology Co., Ltd., established on 2019-08-12, Business scope includes licensed projects:Veterinary drug business;Veterinary drug production;feed production;Feed additive production;Disinfectant production(Free of Hazardous Chemicals);Animal Clinic;pet keeping(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;internet sales(Except for products that require a license for sale);Pharmaceutical special equipment sales;Feed Additive Sales;Disinfectant sales(Free of Hazardous Chemicals);Pet food and supplies retail;Pet Food and Supplies Wholesale;pet sale;Feed Raw Material Sales;pet service(No Animal Treatment);Personal Internet Live Streaming Service;Information Consulting Service(Not including licensing information consulting services);Health Supplies(non food)Production;Health Supplies(non food)Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Scios Inc. is a pharmaceutical company developing drugs for the treatment of cardiovascular and inflammatory diseases. The company is a subsidiary of Johnson & Johnson. The company’s portfolio of drugs includes NatrecorO, a promising drug for heart failure. Scios Inc. was founded in 1981 and is based in California.